![Molecules | Free Full-Text | Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity | HTML Molecules | Free Full-Text | Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity | HTML](https://www.mdpi.com/molecules/molecules-25-01065/article_deploy/html/images/molecules-25-01065-g001.png)
Molecules | Free Full-Text | Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity | HTML
![Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial - The Lancet Neurology Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2e3cbd4e-6095-448f-9448-b8a3500cabab/gr1.gif)
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial - The Lancet Neurology
![Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System - Borrelli - 2018 - Epilepsia - Wiley Online Library Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System - Borrelli - 2018 - Epilepsia - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a13a6592-9f1f-4d21-9e4e-734a28378d82/epi14591-fig-0001-m.jpg)
Stevens‐Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System - Borrelli - 2018 - Epilepsia - Wiley Online Library
![The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness - The Lancet Psychiatry The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness - The Lancet Psychiatry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fcbb7840-1329-40a5-85c3-d2dacfdd61ec/gr1_lrg.jpg)
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness - The Lancet Psychiatry
![Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial. - Abstract - Europe PMC Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5710324/bin/jamaneurol-74-919-g002.jpg)
Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial. - Abstract - Europe PMC
![Molecules | Free Full-Text | Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity | HTML Molecules | Free Full-Text | Investigation of the Absorption of Nanosized lamotrigine Containing Nasal Powder via the Nasal Cavity | HTML](https://www.mdpi.com/molecules/molecules-25-01065/article_deploy/html/images/molecules-25-01065-g006.png)